During the first year of OA-07, patients received a second injection of either LOR or placebo. The second year involved a ...
Upadacitinib 15 mg plus a 26-week GC taper outperformed placebo in combination with a 52-week GC taper for the treatment of ...
WASHINGTON -- Giant cell arteritis (GCA) can be successfully treated with the oral Janus kinase (JAK) inhibitor upadacitinib ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback